terazosin (Q280786)

terazosin (English)

18 November 2016

C₁₉H₂₅N₅O₄

1 reference

terazosin (English)

18 November 2016

COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC

1 reference

https://www.whocc.no/atc_ddd_index/?code=G04CA03

terazosin (English)

18 November 2016

5 milligram

route of administration

oral administration

1 reference

reference URL

World Health Organisation international non-proprietary name

terazosin (English)

1 reference

terazosin (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

prostatic hypertrophy

2 references

13 December 2016

Drug Indications Extracted from FAERS

2 October 2018

arterial hypertension

2 references

13 December 2016

Drug Indications Extracted from FAERS

2 October 2018

10 February 2000

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/8L5014XET7

2 November 2018

reference URL

http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75140_Terazosin%20Hydrochloride_prntlbl.pdf

arterial hypertension

start time

11 February 2000

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/8L5014XET7

2 November 2018

reference URL

http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75140_Terazosin%20Hydrochloride_prntlbl.pdf

significant drug interaction

verapamil

1 reference

hypothetically

A reference set of clinically relevant adverse drug-drug interactions

avanafil

1 reference

hypothetically

A reference set of clinically relevant adverse drug-drug interactions

(RS)-metoprolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vardenafil

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

nadolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atenolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nebivolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sildenafil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acebutolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betaxolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tadalafil

1 reference

hypothetically

A reference set of clinically relevant adverse drug-drug interactions

bisoprolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pindolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

carvedilol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

labetalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celiprolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levobunolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Adrenoceptor alpha 1A

subject has role

antagonist

1 reference

17 August 2016

Adrenoceptor alpha 1B

subject has role

antagonist

1 reference

17 August 2016

Adrenoceptor alpha 1D

subject has role

antagonist

1 reference

LiverTox likelihood score

17 August 2016

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Terazosin

8 January 2018

1 reference

5 March 2018

adrenergic alpha-1 receptor antagonists

1 reference

InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Terazosin

0 references

Identifiers

InChI

1 reference

terazosin (English)

18 November 2016

2 references

terazosin (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

63590-64-7

2 references

terazosin (English)

18 November 2016

https://commonchemistry.cas.org/detail?cas_rn=63590-64-7

9 April 2021

1 reference

Terazosin (English)

18 November 2016

1 reference

terazosin (English)

18 November 2016

Reaxys registry number

719452

1 reference

terazosin (English)

3 October 2016

mapping relation type

2 references

TERAZOSIN (English)

18 November 2016

International Chemical Identifier

InChI

InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)

1 reference

TERAZOSIN (English)

18 November 2016

2 references

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.118.191

27 December 2018

ECHA Substance Infocard ID

6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine (English)

quotation

CAS no.: 63590-64-7 (English)

100.118.191

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.118.191

27 December 2018

6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine (English)

quotation

CAS no.: 63590-64-7 (English)

1 reference

Terazosin (English)

publication date

17 November 2015

1 reference

terazosin (English)

18 November 2016

1 reference

Medical Subject Headings

14 March 2018

1 reference

terazosin (English)

18 November 2016

1 reference

Human Metabolome Database ID

HMDB0015293

2 references

based on heuristic

inferred from InChIKey

2 references

terazosin (English)

18 November 2016

MedlinePlus drug identifier

0 references

1 reference

terazosin (English)

18 November 2016

0 references

1 reference

1 reference

terazosin (English)

3 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

terazosin (English)

3 October 2016

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

Römpp online ID

RD-20-00687

1 reference

imported from Wikimedia project

1 reference

terazosin (English)

18 November 2016

0 references

WordNet 3.1 Synset ID

04419685-n

1 reference